College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
School of Nursing, Shandong University of Traditional Chinese Medicine, Jinan, China.
J Ethnopharmacol. 2024 Jun 28;328:118000. doi: 10.1016/j.jep.2024.118000. Epub 2024 Mar 26.
Xiaoer Niuhuang Qingxin Powder (XNQP) is a classic traditional Chinese medicine formula with significant clinical efficacy for treating febrile convulsions and influenza.
This study aims to explore the potential mechanisms of XNQP in combating combating the influenza A virus, providing a theoretical basis for its clinical application.
The present investigation employed network pharmacology and bioinformatics analysis to determine the TLR4/MyD88/NF-κB signaling pathway as a viable target for XNQP intervention in IAV infection.Subsequently, a mouse model of influenza A virus infection was established, and different doses of XNQP were used for intervention. The protein expression levels of TLR4/MyD88/NF-κB were detected using HE staining, Elisa, immunohistochemistry, immunofluorescence, and western blot.
The results showed that treatment with XNQP after IAV infection reduced the mortality and prolonged the survival time of infected mice. It reduced the release of TNF-α and IFN-γ in the serum and alleviated pathological damage in the lung tissue following infection. Additionally, the levels of TLR4, MyD88, NF-κB, and p-NF-κB P65 proteins were significantly reduced in lung tissue by XNQP. The inhibitory effect of XNQP on the expression of MyD88 and NF-κB was antagonized when TLR4 signaling was overexpressed. Consequently, the expression levels of MyD88, NF-κB, and p-NF-κB P65 were increased in lung tissue. Conversely, the expression levels of the proteins MyD88, NF-κB, and p-NF-κB P65 were downregulated when TLR4 signaling was inhibited.
XNQP alleviated lung pathological changes, reduced serum levels of inflammatory factors, reduced mortality, and prolonged survival time in mice by inhibiting the overexpression of the TLR4/MyD88/NF-κB signaling pathway in lung tissues after IAV infection.
小儿牛黄清心散(XNQP)是一种经典的中药方剂,具有显著的临床疗效,可用于治疗高热惊厥和流感。
本研究旨在探讨 XNQP 对抗甲型流感病毒的潜在机制,为其临床应用提供理论依据。
本研究采用网络药理学和生物信息学分析方法,确定 TLR4/MyD88/NF-κB 信号通路是 XNQP 干预 IAV 感染的潜在靶点。随后,建立了甲型流感病毒感染的小鼠模型,并使用不同剂量的 XNQP 进行干预。采用 HE 染色、ELISA、免疫组化、免疫荧光和 Western blot 检测 TLR4/MyD88/NF-κB 蛋白的表达水平。
结果表明,感染后给予 XNQP 治疗可降低感染小鼠的死亡率并延长其存活时间。它可降低血清中 TNF-α和 IFN-γ的释放,并减轻感染后肺组织的病理损伤。此外,XNQP 可显著降低肺组织中 TLR4、MyD88、NF-κB 和 p-NF-κB P65 蛋白的水平。当 TLR4 信号过度表达时,XNQP 对 MyD88 和 NF-κB 表达的抑制作用被拮抗,从而导致肺组织中 MyD88、NF-κB 和 p-NF-κB P65 的表达水平增加。相反,当抑制 TLR4 信号时,肺组织中 MyD88、NF-κB 和 p-NF-κB P65 蛋白的表达水平降低。
XNQP 通过抑制 IAV 感染后肺组织中 TLR4/MyD88/NF-κB 信号通路的过度表达,减轻肺组织的病理变化,降低血清中炎症因子的水平,降低死亡率,延长感染小鼠的存活时间。